Similar trends were observed across grade I, II, and III hepatotoxicity groups, but the difference did not reach statistical significance (Fig. 2 ).
← all excerpts
Observation of hepatotoxicity during long-term gefitinib administration in patients with non-small-cell lung cancer.
1
—
—